Nora Pencheva, Ph.D.

Associate Director, Translational Medicine Lead at Genmab B.V.

Nora Pencheva, PhD joined Genmab in 2017 as Senior Scientist and currently serves as Associate Director in the Translational Medicine department at Genmab. She is the Translational Medicine Lead on DuoBody®-PD-L1x4-1BB (GEN1046) jointly developed by Genmab and BioNTech for the treatment of solid tumors. Prior to joining Genmab, Dr. Pencheva was an HFSP postdoctoral fellow at the Netherlands Cancer Institute. She completed her PhD training in Molecular and Cellular Biology at the Rockefeller University in New York and received the Harold M. Weintraub award from the Fred Hutchinson Cancer Research Center for outstanding achievements during her graduate research. Dr. Pencheva holds a BSc degree in Neuroscience from Kenyon College, OH USA.